期刊
NATURE MEDICINE
卷 16, 期 9, 页码 991-994出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2202
关键词
-
资金
- US Defense Threat Reduction Agency [HDTRA1-07-C-010, 4.10022-08-RD-B, TMTI0048-09-RD-T]
Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects >60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据